Treatment of duchenne muscular dystrophy

There are disclosed compounds of Formula (1). Pharmaceutical compositions containing the compounds are also provided. Methods of treatment of Duchenne muscular dystrophy, Becker muscular dystrophy and cachexia using the compounds and compositions are also provided.

Saved in:
Bibliographic Details
Main Authors VAN WELL RENATE, LECCI CRISTINA, DE MOOR OLIVIER, WREN STEPHEN PAUL, JOHNSON PETER DAVID, STORER RICHARD, POIGNANT SEVERINE, WYNNE GRAHAM MICHAEL
Format Patent
LanguageChinese
English
Published 27.04.2011
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
DERIVATIVES THEREOF
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
Online AccessGet full text

Cover

Abstract There are disclosed compounds of Formula (1). Pharmaceutical compositions containing the compounds are also provided. Methods of treatment of Duchenne muscular dystrophy, Becker muscular dystrophy and cachexia using the compounds and compositions are also provided.
AbstractList There are disclosed compounds of Formula (1). Pharmaceutical compositions containing the compounds are also provided. Methods of treatment of Duchenne muscular dystrophy, Becker muscular dystrophy and cachexia using the compounds and compositions are also provided.
Author STORER RICHARD
JOHNSON PETER DAVID
POIGNANT SEVERINE
DE MOOR OLIVIER
VAN WELL RENATE
WYNNE GRAHAM MICHAEL
LECCI CRISTINA
WREN STEPHEN PAUL
Author_xml – fullname: VAN WELL RENATE
– fullname: LECCI CRISTINA
– fullname: DE MOOR OLIVIER
– fullname: WREN STEPHEN PAUL
– fullname: JOHNSON PETER DAVID
– fullname: STORER RICHARD
– fullname: POIGNANT SEVERINE
– fullname: WYNNE GRAHAM MICHAEL
BookMark eNrjYmDJy89L5WTQCClKTSzJTc0rUchPU0gpTc5IzctLVcgtLU4uzUksUkipLC4pyi_IqORhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHOfoYGRgbGZpbmRo7GxKgBAOZeKn4
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID CN102036972A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN102036972A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:57:37 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN102036972A3
Notes Application Number: CN200880016006
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110427&DB=EPODOC&CC=CN&NR=102036972A
ParticipantIDs epo_espacenet_CN102036972A
PublicationCentury 2000
PublicationDate 20110427
PublicationDateYYYYMMDD 2011-04-27
PublicationDate_xml – month: 04
  year: 2011
  text: 20110427
  day: 27
PublicationDecade 2010
PublicationYear 2011
RelatedCompanies SUMMIT CORP. PLC
RelatedCompanies_xml – name: SUMMIT CORP. PLC
Score 2.9141855
Snippet There are disclosed compounds of Formula (1). Pharmaceutical compositions containing the compounds are also provided. Methods of treatment of Duchenne muscular...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
DERIVATIVES THEREOF
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
Title Treatment of duchenne muscular dystrophy
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110427&DB=EPODOC&locale=&CC=CN&NR=102036972A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTRJMUoyNrXUTTG2MNM1MTRI1LU0SEvSTTK0TDS2MEhJNEgCbRT29TPzCDXxijCNYGLIgu2FAZ8TWg4-HBGYo5KB-b0EXF4XIAaxXMBrK4v1kzKBQvn2biG2LmopsOE-0NURai5Otq4B_i7-zmrOzrbOfmp-QcC2LmjGzdLcyJGZgRXYjDYH5QbXMCfQrpQC5CrFTZCBLQBoWl6JEANTVYYwA6cz7OY1YQYOX-iEN5AJzXvFIgwaIbA14Qr5aQoppcDQBpaRCrmlkKWkCimVQN35wFATZVB0cw1x9tAFWhkP91-8sx_CdcZiDCzAfn-qBIOCeZpJMmh7UUpiYqJJUhJQGliuAvsDlinAPk5ioqkkgxRuc6TwSUozcEGGRk10jcxlGFhKikpTZYF1a0mSHDhQAC1MfZo
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTRJMUoyNrXUTTG2MNM1MTRI1LU0SEvSTTK0TDS2MEhJNEgCbRT29TPzCDXxijCNYGLIgu2FAZ8TWg4-HBGYo5KB-b0EXF4XIAaxXMBrK4v1kzKBQvn2biG2LmopsOE-0NURai5Otq4B_i7-zmrOzrbOfmp-QcC2LmjGzdLcyJGZgRXYxDYH5QbXMCfQrpQC5CrFTZCBLQBoWl6JEANTVYYwA6cz7OY1YQYOX-iEN5AJzXvFIgwaIbA14Qr5aQoppcDQBpaRCrmlkKWkCimVQN35wFATZVB0cw1x9tAFWhkP91-8sx_CdcZiDCzAfn-qBIOCeZpJMmh7UUpiYqJJUhJQGliuAvsDlinAPk5ioqkkgxRuc6TwScozcHqE-PrE-3j6eUszcEGGSU10jcxlGFhKikpTZYH1bEmSHDiAADwdgI0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Treatment+of+duchenne+muscular+dystrophy&rft.inventor=VAN+WELL+RENATE&rft.inventor=LECCI+CRISTINA&rft.inventor=DE+MOOR+OLIVIER&rft.inventor=WREN+STEPHEN+PAUL&rft.inventor=JOHNSON+PETER+DAVID&rft.inventor=STORER+RICHARD&rft.inventor=POIGNANT+SEVERINE&rft.inventor=WYNNE+GRAHAM+MICHAEL&rft.date=2011-04-27&rft.externalDBID=A&rft.externalDocID=CN102036972A